Vitamin B5 Prices Rebound Globally Amid Strong Downstream Demand and Inventory Realignment

Vitamin B5 Prices Rebound Globally Amid Strong Downstream Demand and Inventory Realignment

Peter Schmidt 01-Aug-2025

The global Vitamin B5 market witnessed a rebound in July 2025 as buyers resumed procurement following a cautious pause in June. Inventory drawdowns occurred as downstream sectors—including pharmaceuticals, nutraceuticals, food, and personal care—maintained steady production. Strategic pricing by suppliers aligned with consistent demand, especially as seasonal consumption began to rise. With no major logistical disruptions, supply chains remained stable. The market environment is now shaped by active inventory realignment and anticipatory buying behaviour, suggesting that stakeholders should closely monitor evolving demand and global market cues moving forward.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.